Corgenix Medical Corporation Announces New AtherOx® (Oxidized LDL Technology) License and Cooperation Agreement

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCQB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, today announced signing of a new AtherOx® License and Cooperation Agreement with Eiji Matsuura, Ph.D., an individual of Okayama, Japan. Concurrently with the execution of the new agreement, Dr. Matsuura terminated his arbitration demand of June 28, 2013 related to the April 14, 2010 Amended and Restated License Agreement between the parties.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC